Clinical Trial Update: A Prospective Imaging Study of the Integrated TrueBeam-HyperSight CBCT System [NA]

View source ↗

Summary

Clinical trial update for the integrated TrueBeam-HyperSight CBCT imaging system; the study (NCT05975619) sponsored by Varian is active but not recruiting, eval…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer
• Head and Neck Cancer
• Pelvic Cancer
• Thoracic Cancer

Drugs mentioned

• Integrated TrueBeam-HyperSight CBCT System

Snippet

Sponsor: Varian, a Siemens Healthineers Company | Conditions: Head and Neck Cancer, Thoracic Cancer | NA | Status: ACTIVE_NOT_RECRUITING